The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study to assess safety, pharmacokinetics (PK), and pharmacodynamics (PD) of JNJ-64457107, a CD40 agonistic monoclonal antibody, in patients (pts) with advanced solid tumors.
 
Emiliano Calvo
Employment - HM Hospitales; START
Leadership - START
Stock and Other Ownership Interests - International Cancer Consultants; Oncoart Associated; START
Honoraria - HM Hospitales
Consulting or Advisory Role - Abbvie; Amcure; AstraZeneca; Celgene; EUSA Pharma; Gerson Lehrman Group; Guidepoint Global; Janssen-Cilag; Nanobiotix; Novartis; Pfizer; PsiOxus Therapeutics; Roche/Genentech; Seagen; SERVIER
Speakers' Bureau - Novartis
Research Funding - AstraZeneca; BeiGene; Novartis; START
Travel, Accommodations, Expenses - Roche/Genentech
Other Relationship - Investigational Therapeutics in Oncological Sciences
 
Victor Moreno
Employment - START
Consulting or Advisory Role - Merck
Research Funding - Abbvie (Inst); ACEA Biosciences (Inst); Adaptimmune (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); E-therapeutics (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Menarini (Inst); Merck (Inst); Nanobiotix (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); PsiOxus Therapeutics (Inst); Puma Biotechnology (Inst); Regeneron (Inst); RigonTEC (Inst); Roche (Inst); Sanofi (Inst); Sierra Oncology (Inst); Synthon (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Tesaro (Inst); Transgene (Inst)
Expert Testimony - Medscape/Bayer; Nanobiotix
Travel, Accommodations, Expenses - Sanofi/Regeneron
 
Ruth Perets
Honoraria - Bristol-Myers Squibb
 
Tamar Yablonski-Peretz
Consulting or Advisory Role - AstraZeneca; Medison; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Roche
 
Nele Fourneau
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Suzette Girgis
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Yue Guo
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Peter Hellemans
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
David Hokey
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Natalia Pendas Franco
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Qi Xia
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Ravit Geva
Honoraria - Bristol-Myers Squibb; Janssen; Lilly; Medison; MSD; Novartis; Pfizer; Roche; Teva
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche